Background-Currently, only x-ray fluoroscopy is available for visualization of the extrahepatic bile ducts intraoperatively. We hypothesized that with an appropriate fluorophore and imaging system, invisible near-infrared (NIR) light could be used for image-guided procedures on the extrahepatic bile ducts.
INTRODUCTION
Intraoperative x-ray cholangiography (IOC), performed by direct injection of iodine contrast medium into the CBD, is used for its anatomic visualization, as well as intraoperative diagnosis of stones and injuries. The use of IOC is still controversial, and opinions are split between routine 1,2,3 and selective use. 4 Nevertheless, the incidence of CBD stones is approximately 3.3%, 5 and the detection rate of CBD abnormalities or injuries intraoperatively is reported in the range of 18 to 37%, 6, 7, 8 suggesting that biliary complications might be detected earlier and more frequently with its routine use. 6 In addition, early diagnosis of stones and injuries is reported to improve treatment outcome. 5,9,10 Thus, if there were a more convenient method for routine intraoperative assessment of the extrahepatic bile ducts, outcomes might be improved. Intraoperative assessment might also potentially prevent or reduce severe bile duct injuries.
There are various cholegraphic techniques available, including excellent preoperative imaging of stones using ERCP, three-dimensional CT, and MRCP. 11,12 However, none of these techniques are ideal for intraoperative imaging. First, it takes a relatively long time (≈30-60 min) to detect the bile duct following administration of contrast agents (CT) or just to perform the study (ERCP and MRCP). 13 Second, it is difficult to merge pre-operative scans with what the surgeon sees on the operative field. Third, and most important, iodine-based agents have a low, but clinically relevant, rate of adverse reactions. 14,15 Presently, there are no efficient intraoperative imaging modalities for real-time visualization of extrahepatic biliary anatomy and function in the operative field, other than direct injection of iodine contrast agent in conjunction with x-ray fluoroscopy or ultrasonography.
Invisible NIR light in the range of 700 nm to 900 nm has the potential to provide sensitive, specific, and real-time imaging of the extrahepatic bile ducts (reviewed in 16 ). Photon absorption, scatter, and autofluorescence in this wavelength range are relatively low, which provides a low "background" to which a "signal" from exogenous NIR fluorophores can be added. This setting is in sharp contrast to UV and visible wavelength fluorescence, 17 which suffer from high background and relatively low signal. We have described previously an intraoperative NIR fluorescence imaging system that simultaneously acquires color video (i.e., surgical anatomy) along with NIR fluorescence of the surgical field. 18-20 By introducing an exogenous NIR fluorophore that highlights the target of interest, such as extrahepatic bile ducts, the NIR fluorescence channel can be used to pinpoint the location of any desired structure in the operative field and/or to assess its function. To date, this system has been used for high sensitivity sentinel lymph node mapping, 20-32 assessment of tissue and vascular calcification, 33-36 assessment of ischemic reperfusion-related cell injury and death, 37 detection of obscure gastrointestinal bleeding, 38 detection of acute thrombosis, 39 and delivery of gene therapy. 40 Heptamethine indocyanines are a class of NIR fluorophores for which vast human data are available. The prototype molecule, indocyanine green (ICG), has been FDA-approved for other indications since 1958 and has a remarkable safety record. 41, 42 In this study, we compare three different 800 nm heptamethine indocyanines differing primarily in their degree of sulfonation, i.e., hydrophilicity. For each compound, we quantify their efficiency of transport from the bloodstream to extrahepatic bile ducts, their SBR in the bile duct over time, and their performance in assessing extrahepatic biliary anatomy and function.
MATERIALS AND METHODS

Preparation of NIR Fluorophores
IR − 786 perchlorate (IR-786) and sodium ICG were purchased from Sigma (St. Louis, MO). CW800-CA, the carboxylic acid form of IRDye ™ 800CW was obtained from LI-COR (Lincoln, NE). IR-786 was diluted to 100 μM in phosphate-buffered saline (PBS) supplemented with 10% Cremophor EL (Sigma) and 10% absolute ethanol immediately before use. Stock solutions of 10 mM ICG and 18 mM CW800-CA were stored in DMSO at −80ºC in the dark. ICG and CW800-CA were diluted in PBS as indicated below before use. Quantum yields of contrast agents in 100% fetal bovine serum (FBS) were calculated using ICG in dimethyl sulfoxide (quantum yield 13% 43 ) as the calibration standard, under conditions of matched fluorophore absorbance.
Animal Model Systems
Animals were used in accordance with an approved institutional protocol. Adult, male, 330 g, Sprague-Dawley rats from Charles River Laboratories (Wilmington, MA) were anesthetized with 65 mg/kg intraperitoneal pentobarbital. Adult, female, 30 kg Yorkshire pigs (E.M. Parsons and Sons, Hadley, MA) were induced with 4.4 mg/kg intramuscular Telazol (Fort Dodge Labs, Fort Dodge, IA), then intubated and maintained with 1.5-2.0% isoflurane/balance O 2 .
Bile Duct Imaging
Portal vein injection in rats (N = 3 rats per NIR fluorophore) was performed with a 30-gauge, 1/2" needle using the following volumes and concentrations of stock solutions: IR-786 (50 μL of a 100 μM stock; 0.015 μmol/kg final; 9 μg/kg final), ICG (50 μL of a 1 mM stock; 0.15 μmol/kg final; 120 μg/kg final), and CW800-CA (50 μL of a 100 μM stock; 0.015 μmol/kg final; 15 μg/kg final). Fluorescence intensities of the CBD, pancreas, and right lobe of the liver were measured with the same regions of interests at 3, 5, 10, 20, and 30 min following injection of each NIR fluorophore.
For quantifying the dose-response of CW800-CA, the CBD was visualized after systemic (tail vein) IV injection (N = 4 rats per dose) or portal vein injection (N = 4 rats per dose) of 50 μL of CW800-CA having a stock concentration of 10, 20, 50, and 100 μM, corresponding to final doses of 0.0015 μmol/kg (1.5 μg/kg), 0.003 μmol/kg (3 μg/kg), 0.0075 μmol/kg (7.5 μg/kg), and 0.015 μmol/kg (15 μg/kg), respectively. Fluorescence intensities of the CBD, pancreas, and right lobe of the liver were measured with the same regions of interests at 3, 5, 10, 20, and 30 min following injection of each NIR fluorophore.
In anesthetized pigs, 5 mL of 100 μM of CW800-CA (0.015 μmol/kg; 15 μg/kg final) were injected into the portal vein (N = 3 pigs) and 5 mL of either 50 μM (N = 3 pigs; 0.0075 μmol/ kg; 7.5 μg/kg) or 100 μM (N = 3 pigs; 0.015 μmol/kg; 15 μg/kg) of CW800-CA were injected systemically (ear vein). Radiolucent globular beads (2.5 mm in diameter) or cylindrical beads (3.5 mm in long axis) were inserted into the CBD via the papilla of Vater after duodenotomy (N = 2 pigs). These were used to simulate different sizes and shapes of CBD stones seen in patients. An additional N = 2 pigs received direct injection of 10 ml of 10 μM ICG into the cystic duct.
A previously described 20 simultaneous color video/NIR fluorescence intraoperative imaging system was employed for quantification of all NIR fluorescence images. White light (400-700 nm) and NIR fluorescence excitation light (725-775 nm) was used at 1 mW/cm 2 and 5 mW/ cm 2 , respectively. Spatial resolution at a field-of-view of 20 × 15 cm is 625 μm, and at a fieldof-view of 4 × 3 cm is 125 μm. After computer-controlled camera acquisition via custom LabVIEW (National Instruments, Austin, TX) software, anatomic (white light) and functional (NIR fluorescence light) images were displayed separately and merged. To create a single image that displays both anatomy (color video) and function (NIR fluorescence), the NIR fluorescence image was pseudo-colored in lime green and overlaid with 100% transparency on top of the color video image of the same surgical field. All images were refreshed up to 15 times per second. The entire apparatus was suspended on an articulated arm over the surgical field, thus permitting non-invasive and non-intrusive imaging. Hands-free operation utilizing motorized zoom and focus lenses, a four-pedal footswitch, and a multifunction data acquisition board were described in detail previously. 44
Gel-Filtration Chromatography
Bile was collected from the CBD using a needle and syringe, flash frozen in LN 2 , and stored at −80°C until analyzed. After thawing, samples were diluted immediately 1:1 in phosphatebuffered saline, pH 7.4 (PBS) and separated using an AKTA Prime chromatography system (Amersham Bioscience, Piscataway, NJ) equipped with an Econo-Pac P6 (6,000 MW cutoff; Bio-Rad Laboratories, Hercules, CA) gel-filtration cartridge. The mobile phase was PBS and the flow rate was 0.5 ml/min. Online, full-spectrum absorbance (200-1100 nm) and fluorescence (350-1000 nm) were measured as described in detail previously. 45 Fractions having the highest 783 nm absorbance and 803 nm fluorescence were collected for analysis by mass spectrometry.
High-Performance Liquid Chromatography/Tandem Mass Spectrometry (LC/MS)
Twenty-five microliters of each gel-filtration sample was analyzed on a Waters (Milford, MA) LCT electrospray (ES) time-of-flight (TOF) LC/MS equipped with dual-absorbance detectors, fluorescence detector, Sedex model 75 evaporative light scatter detector (ELSD; Richards Scientific, Novato, CA), and lockspray, as described in detail previously. 46 Briefly, the absorbance detectors were set to 280 nm and 700 nm (the maximum permitted wavelength). The fluorescence detector was set to 803 nm using 770 nm excitation light. Bovine heart myoglobin (5 μM) in water was used as a mass reference for the lockspray. Buffer A was 10 mM triethylammonium acetate (TEAA; Glen Research, Sterling, VA) and Buffer B was absolute methanol (Aaper Alcohol and Chemical, Shelbyville, KY). Using a gradient of 0 to 70% B over 20 min, bile samples were resolved on a 4.6 × 150 mm Symmetry (Waters) C 18 column at a flow rate of 1 ml/min, with the eluate split equally to the ELSD and MS detectors. The ion mode was set to ES − , and cone and capillary voltages were 30 V and 3000 V, respectively. Desolvation and source temperature were 350°C and 140°C, respectively. Data were analyzed with MassLynx (Waters) software.
RESULTS
NIR Fluorescent Contrast Agents for Imaging the Extrahepatic Bile Ducts
The heptamethine indocyanines IR-786, ICG, and CW800-CA possess 0, 2, and 4 sulfonate groups, respectively, and hence increasing hydrophilicity ( Figure 1A ). Although all three have similar chemical structures and peak emission wavelengths ≈800 nm, their quantum yield in serum increases with hydrophilicity. So, too, does the efficiency of excretion into bile (this study) and urine 47 after intravenous injection, with the tetra-sulfonated compound CW800-CA showing superior performance.
Portal Vein Injection of NIR Fluorescent Contrast Agents
To optimize visualization of the extrahepatic bile ducts, NIR fluorescent contrast agents were injected initially into the portal vein. As shown in Figure 1B , all three agents provided imageguided identification of the extrahepatic bile ducts but differed greatly in their performance. IR-786 and ICG were excreted poorly into bile with an extremely low signal relative to liver background. Also, ICG required ten-fold higher doses to achieve reasonable bile duct labeling. On the contrary, CW800-CA was transferred from the liver into bile with extremely low liver retention ( Figure 1B ) and background ( Figure 1C ). Indeed, a single portal vein injection of CW800-CA resulted in an SBR ≥2.5 starting 3 min after injection, peaking at 5-10 min and continuing for at least 30 min. The dose-response curve of CW800-CA (Figure 2, top) suggested that doses greater than 0.0015 μmol/kg provided the highest SBR, with a dose of 0.0075-0.015 μmol/kg being optimal for prolonged visualization.
Systemic Injection of NIR Fluorescent Contrast Agents
Because injection into the portal vein injection is not ideal, we next determined whether a simple, peripheral IV injection of CW800-CA would permit sensitive imaging of the extrahepatic bile ducts. As shown in Figure 2 (bottom), a single IV injection of CW800-CA into rats at doses greater than 0.0015 μmol/kg resulted in a high SBR of the CBD for at least 30 min post-injection, with a dose of 0.0075 μmol/kg being optimal.
Visualization of Normal and Abnormal Bile Ducts in Large Animal Model Systems
Based on the results from rats, CW800-CA was chosen for large animal studies. Initial doseresponse curves (data not shown) suggested that a dose of 0.015 μmol/kg injected into the portal vein (N = 3 pigs), and either 0.0075 μmol/kg (N = 3 pigs) or 0.015 μmol/kg (N = 3 pigs) injected systemically, resulted in SBR ≥2.5 starting from 5 min and continuing for at least 30 min post-injection. Figure 3A shows representative imaging of the normal extrahepatic bile duct system after a single systemic IV injection of 0.0075 μmol/kg CW800-CA. Visualization lasted at least 30 min, and the systemic injection could be repeated as many times as necessary (data not shown) to complete the operation. Importantly, contrast in the CBD is great enough to detect the presence of small (2.5-3.5 mm) radiolucent inclusions ( Figure 3B ). Because ICG is already FDA-approved for other indications and is available in the clinic, and since neither portal vein nor systemic injection results in a high and predictable biliary concentration ( Figure  1B) , we tested the direct injection of ICG into the extrahepatic bile duct via the cystic duct. A dose of 10 μM was chosen, because it provides the highest possible fluorescence emission without dye quenching. 24 As shown in Figure 3C , direct injection provided immediate imaging of both distal and proximal extrahepatic bile ducts with an SBR ≥3 for over 30 min.
Analysis of NIR Fluorophore Chemical Form in Bile
Although there was an NIR fluorescent substance in bile after intravenous injection of CW800-CA, it is possible that the fluorophore was metabolized during excretion. To determine the chemical form of the NIR fluorophore in bile, a combination of gel-filtration and LC/MS analyses were performed. As shown in Figure 4A , separation of control bile on a 6,000 Da cutoff column confirmed that there are no endogenous NIR fluorophores present. Separation of bile aspirated from the CBD 15 min after injection of 0.015 μmol/kg CW800-CA demonstrated that 94% of the NIR fluorescence was non-protein bound, running at ≈1,000 Da in size. The peak fraction was collected and subjected to LC/MS analysis using a C 18 column for separation. As shown in Figure 4B , a single NIR absorbing and fluorescing peak was present, with a retention time (21 min) and mass spectrometric pattern identical to pure CW800-CA. These data suggest that ≈94% of CW800-CA is excreted unchanged into bile and is the major contributor to the 800 nm NIR fluorescence signal in the extrahepatic bile ducts.
DISCUSSION
NIR fluorescence bile duct imaging offers several advantages over IOC by x-ray fluoroscopy including prolonged (at least 30 min), high sensitivity visualization after a single, low-dose, systemic injection, no exposure of patients and caregivers to ionizing radiation, real-time imaging with no moving parts, patient contact, or image reconstruction, and simultaneous acquisition of surgical anatomy (via color video) and bile duct function (via NIR fluorescence). Contrast agents can be stored as dry powders in sterile vials, and resuspended in sterile saline immediately prior to use. Contrast agent injection can also be repeated as many times as needed for long cases. And, bile duct injury can be detected in real-time using this technology (data not shown), as we described previously for ureteral injury. 47 Moreover, because both NIR fluorescence excitation and emission light is invisible to the surgeon, and the NIR fluorophores are used at extremely low doses, there is no alteration to the look of the surgical field.
However, several limitations deserve mention. First, peak contrast doesn't occur for approximately 10 min after IV injection. Second, NIR light has finite depth penetration into scattering tissue, which limits detection to 3-5 mm from the surface. However, at least in rats and pigs, there was never much difficulty in finding quickly and assessing the CBD, because autofluorescence from surrounding structures is low, and the SBR is relatively high. And, third, IV injection of a contrast agent always carries the risk of toxicity. CW800-CA, however, belongs to a class of heptamethine indocyanines with low inherent toxicitiy. 48 In fact, the chemically-related molecule ICG has one of the lowest reported toxicities for any pharmaceutical administered to patients, 41 with toxicity seen only at doses 10-fold higher than those used in the present study.
The chemical form and injection dose of the NIR fluorescent contrast agent are of critical importance for successful visualization of the extrahepatic bile ducts using this technology.
First, there appears to be an important effect of sulfonation, and therefore hydrophilicity, on the efficiency of transfer of NIR fluorescent contrast agents from the bloodstream to the bile. Indeed, the excretion of the tetra-sulfonated compound CW800-CA occurred so quickly that the background signal in the liver was barely detectable (Figures 1B and 3) . On the contrary, non-sulfonated IR-786 and di-sulfonated ICG had tremendously high liver uptake and poor efficiency of excretion into bile.
An optimal dose of CW800-CA would result in a final CBD concentration of ≈10 μM, which is the concentration at which fluorescence emission reaches its peak, and dye stacking and quenching are minimal. 24 As demonstrated in Figure 2 , increasing the dose beyond its optimum results in a lower SBR in the CBD. It also results in the tinting of bile slightly green (the color of CW800-CA in solution), indicating that the concentration in the CBD is too high and fluorescence quenching is occurring. Nevertheless, at least 94% of CW800-CA remains non-protein bound in bile and is chemically unchanged. This observation, coupled with the low dose required (0.0075 μmol/kg or 250 μg in a 33 kg pig), and the chemical similarity to ICG, suggests that translation to the clinic in the near-term should be possible.
Although open surgery for gallbladder disease is still being performed, laparoscopic surgery plays an ever more important role. For this reason, we have adapted our NIR fluorescence imaging system for laparoscopic surgery (unpublished data). The importance of the present study, though, is that the NIR fluorescent contrast agent chemistry for imaging of the extrahepatic biliary system is now defined, and can be applied equally to open surgery and laparoscopic surgery to permit real-time, image-guided assessment of the anatomy and function of the extrahepatic bile ducts. The SBR dose-response of CW800-CA for CBD imaging. The SBR (mean ± SEM) of the CBD relative to liver (left) and pancreas (right) was quantified over time, following portal vein injection (top) or systemic IV injection (bottom) of CW800-CA, at the doses shown, in N = 3 animals per dose. B. Detection of three spherical radiolucent inclusions of 2.5 mm diameter (arrowhead) and one cylindrical radiolucent inclusion of 3.5 mm long axis (arrow) using CW800-CA as described in Figure 3A . Image is representative of N = 2 animals total. C. NIR fluorescence IOC was performed by direct injection of 10 ml of 10 μM ICG into the cystic duct (Cy). Visualization of the CBD (arrowhead) and the proximal second order branch of the left hepatic duct (L) is shown.
